Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

Women with a history of gestational diabetes mellitus (GDM) are at a 2-fold greater risk for the development of overt cardiovascular disease (CVD) following the effected pregnancy. While subsequent development of type II diabetes elevates this risk, prior GDM is an independent risk factor for CVD morbidity, particularly, within the first decade postpartum. GDM is associated with impaired endothelial function during pregnancy and decrements in macro- and microvascular function persist postpartum, despite the remission of insulin resistance following delivery. Collectively, while the association between GDM and elevated lifetime CVD risk is clear, and available evidence demonstrates a link between GDM and vascular dysfunction in the decade following pregnancy, the mechanisms mediating this persistent dysfunction remain unexamined. The purpose of this investigation is to examine the role of endothelin-1, a potent vasoconstrictor, in aberrant microvascular function in otherwise healthy women with a history of GDM and to identify whether this mechanism is influenced by physical activity and sedentary behavior.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• history of pregnancy within 5 years of the study visit

• had healthy pregnancy OR had gestational diabetes diagnosed by their obstetrician and confirmed according to the American College of Obstetricians and Gynecologists criteria for gestational diabetes.

Locations
United States
Iowa
University of Iowa
RECRUITING
Iowa City
Contact Information
Primary
Anna Reid-Stanhewicz, PHD
anna-stanhewicz@uiowa.edu
319-467-1732
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2027-05
Participants
Target number of participants: 40
Treatments
Placebo_comparator: local lactated Ringer's perfusion
lactated Ringer's is perfused through the microdialysis fiber to serve as the vehicle control
Experimental: local BQ-788 and BQ-123 perfusion
local ET-1 inhibitors perfused through the microdialysis fiber to serve as the experimental treatment
Experimental: local L-NAME perfusion
local L-NAME is perfused through the microdialysis fiber to inhibit nitric oxide synthase
Experimental: local BQ-788 + BQ-123 + L-NAME perfusion
local ET-1 inhibitors and L-NAME are perfused through the microdialysis fiber to inhibit nitric oxide synthase during the experimental treatment
Related Therapeutic Areas
Sponsors
Leads: Anna Stanhewicz, PhD

This content was sourced from clinicaltrials.gov